Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells-Reference-Cited by-同舟云学术

Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells

Published:2022-05-25 Issue:1 Volume:48 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Jirapongwattana Niphat¹,Thongchot Suyanee²,Chiraphapphaiboon Wannasiri³,Chieochansin Thaweesak³,Sa‑Nguanraksa Doonyapat⁴,Warnnissorn Malee⁵,Thuwajit Peti²,Yenchitsomanus Pa-Thai³,Thuwajit Chanitra²

Affiliation:

1. Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

2. Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

3. Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE‑CIT), Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

4. Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

5. Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference46 articles.

1. Breast cancer treatment: A review;Waks;JAMA,2019

2. Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity;Reddy;Br J Cancer,2018

3. Treatment strategies and survival outcomes in breast cancer;Cheung;Cancers (Basel),2020

4. Window of opportunity trials for biomarker discovery in breast cancer;Arnedos;Curr Opin Oncol,2019

5. Identification of modulated micrornas associated with breast cancer, diet, and physical activity;Falzone;Cancers (Basel),2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T Cell Therapy for Cancer;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-04-15

2. Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways;Breast Cancer Research;2023-07-21